TrialThe oncologist2025

Phase II single-arm study of palbociclib and cetuximab in anti-EGFR naïve patients with KRAS/NRAS/BRAF wild-type, metastatic colorectal cancer.

Jonathan D Sorah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.